| AbC | Capture antibody |
| Abs | Second antibody |
| ADAM | A disintegrin and metalloprotease |
| ALP | Alkaline phosphatase |
| BTLA | B- and T- lymphocyte attenuator |
| CEA | Carcinoembryonic antigen |
| CLL | Chronic lymphocytic leukemia |
| CRC | Colorectal cancer |
| CT scan | Computed tomography scan |
| CTC | Circulating tumor cells |
| ctDNA | Circulating tumor DNA |
| CTL | Cytotoxic T lymphocytes |
| CTLA-4 | Cytotoxic T-lymphocyte–associated antigen 4 |
| DLBCL | Diffuse large B-cell lymphoma |
| EC | Electrochemical biosensors |
| EGFR | Epidermal growth factor receptor |
| ELISA | Enzyme-linked immunoassay |
| FRET | Fluorescence resonance energy transfer |
| GSPE-MFD | Gold screen-printed electrode-based microfluidic devices |
| HCC | Hepatocellular carcinoma |
| HER2 | Human epidermal growth factor receptor 2 |
| Hq | Hydroquinone |
| HRP | Horse radish peroxide |
| IC | Immune checkpoints |
| ICB | Immue checkpoint blockade |
| IFN-γ | Interferon gamma |
| IgG | Immunoglobulin G |
| IHC | Immunohistochemistry |
| IL-2 | Interleukin-2 |
| LAG-3 | Lymphocyte activation gene 3 |
| LOD | Limit-of-detection |
| MAGE-A | Melanoma-associated antigen-A |
| MICB | Multiplexed immune checkpoint biosensor |
| MNP | Magnetic nanoparticles |
| MUC1 | Mucin 1 |
| NPC | Nasopharyngeal carcinoma |
| NTME | Non-tumor microenvironment |
| PD-1 | Programmed death 1 |
| PD-L1 | Programmed death-1 ligand |
| PSA | Prostate specific antigen |
| PTC | Papillary thyroid cancer |
| ScFv | Single-chain variable fragment |
| sLAG-3 | Serum lymphocyte activation gene-3 |
| sPD-1 | Serum programmed death-1 |
| sPD-L1 | Serum programmed death-1 ligand |
| SPR | Surface plasmon resonance |
| sTIM-3 | Serum T cell immunoglobulin and mucin-domain containing-3 |
| TAA | Tumor-associated antigen |
| TIM-3 | T cell immunoglobulin and mucin-domain containing-3 |
| TME | Tumor microenvironment |
| TNF-α | Tumor necrosis factor alpha |
| TSA | Tumor-specific antigen |